Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × INDUSTRY × Omeprazole × Clear all

Phase

Phase 1 19 Phase 2 3 Phase 4 1 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 3 NIH 2 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Carboplatin 262 Paclitaxel 256 Cisplatin 208 Docetaxel 204 pembrolizumab 187 Gemcitabine 177 Pemetrexed 133 Rituximab 124 Capecitabine 122 Bevacizumab 116 Dexamethasone 103 Fluorouracil 94 Cyclophosphamide 90 Doxorubicin 89 Prednisone 83 Trastuzumab 82 Nivolumab 77 Oxaliplatin 73 atezolizumab 64 durvalumab 61 Injections 59 Leucovorin 56 Lenalidomide 56 130-nm albumin-bound paclitaxel 55 Irinotecan 48 Drug Therapy 48 Bortezomib 46 Fulvestrant 45 Letrozole 43 Bendamustine Hydrochloride 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05646862 2026-02-05

INAVO121

Hoffmann-La Roche

Phase 3 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡